PDI to promote and support Apligraf:
This article was originally published in Clinica
Executive Summary
PDI's devices & diagnostics unit will provide sales, marketing and clinical support for Apligraf, Organogenesis's living bi-layered skin substitute used in the treatment of diabetic ulcers and venous leg ulcers. Under the deal, Upper Saddle River, New Jersey-based PDI will receive a fee with the potential to earn performance-based incentives.